Australia markets closed

Vectus Biosystems Limited (VBS.AX)

ASX - ASX Delayed price. Currency in AUD
Add to watchlist
0.2350-0.0150 (-6.00%)
At close: 10:31AM AEST
Currency in AUD

Valuation measures4

Market cap (intra-day) 12.50M
Enterprise value 9.62M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)N/A
Price/book (mrq)5.28
Enterprise value/revenue 53.46k
Enterprise value/EBITDA -3.97

Trading information

Stock price history

Beta (5Y monthly) 0.83
52-week change 3-53.00%
S&P500 52-week change 323.57%
52-week high 30.5200
52-week low 30.2000
50-day moving average 30.2609
200-day moving average 30.3250

Share statistics

Avg vol (3-month) 37.96k
Avg vol (10-day) 33.04k
Shares outstanding 553.21M
Implied shares outstanding 656.61M
Float 823.27M
% held by insiders 148.81%
% held by institutions 18.43%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 June 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin -174.84%
Operating margin (ttm)-181.26%

Management effectiveness

Return on assets (ttm)-34.23%
Return on equity (ttm)-69.10%

Income statement

Revenue (ttm)1.42M
Revenue per share (ttm)0.03
Quarterly revenue growth (yoy)11.90%
Gross profit (ttm)N/A
EBITDA -2.43M
Net income avi to common (ttm)-2.49M
Diluted EPS (ttm)-0.0400
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)2.09M
Total cash per share (mrq)0.04
Total debt (mrq)27.43k
Total debt/equity (mrq)1.16%
Current ratio (mrq)3.71
Book value per share (mrq)0.05

Cash flow statement

Operating cash flow (ttm)-1.31M
Levered free cash flow (ttm)-832.18k